Loading clinical trials...
Loading clinical trials...
A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.
Conditions
Interventions
GWP42006
Placebo Control
Locations
26
Czechia
Havířov, Czechia
Hradec Králové, Czechia
Prague, Czechia
Rychnov nad Kněžnou, Czechia
Budapest, Hungary
Esztergom, Hungary
Start Date
March 1, 2016
Primary Completion Date
July 1, 2017
Completion Date
September 1, 2017
Last Updated
December 20, 2022
NCT02531880
NCT06097195
NCT06315322
NCT06388707
NCT06794606
NCT07505004
Lead Sponsor
Jazz Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions